EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-SA 4.0

Updates in the treatment of neovascular glaucoma: From conventional approaches to novel therapies

Saurabh Verma, Neha Midha, Hemlata Udenia, Tanuj Dada

Indian Journal of Ophthalmology · 2025

DOI: 10.4103/ijo.ijo_841_25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Indian Journal of Ophthalmology, 2025. Verfasst von Saurabh Verma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi, India. Hauptthemen laut MEDLINE: Glaucoma, Neovascular, Intraocular Pressure, Laser Coagulation, Angiogenesis Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neovascular glaucoma (NVG) is a severe and refractory form of secondary glaucoma characterized by the proliferation of abnormal vessels in the anterior segment, leading to a progressive rise in intraocular pressure (IOP) and optic nerve damage. It is most commonly associated with ischemic retinal conditions such as diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome. This review aims to provide an updated overview of the current management strategies for NVG, including recent advancements in medical, laser, and surgical treatment modalities. While anti-vascular endothelial growth factor (VEGF) agents have revolutionized early NVG management, panretinal photocoagulation (PRP) remains the cornerstone of ischemia management, with enhancements in laser delivery improving efficacy and safety. Filtration surgeries like trabeculectomy and glaucoma drainage devices offer equivocal results in NVG, and on the other hand, safer cyclodestructive methods like transscleral micropulse and endoscopic cyclophotocoagulation (ECP) have emerged as promising alternatives with reduced complications. The management of NVG requires a multimodal approach involving the primary physician, retina specialist, and a glaucoma specialist with treatment tailored to disease severity and underlying retinal pathology. Further research is needed to optimize treatment algorithms and explore emerging therapies for this challenging condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glaucoma, NeovascularIntraocular PressureLaser CoagulationAngiogenesis InhibitorsDisease ManagementTrabeculectomyHumans

Stichwörter der Autor:innen

Anti-VEGFcyclophotocoagulationglaucoma drainage implantglaucoma filtration surgeryneovascular glaucomaneovascularizationpanretinal photocoagulationtrabeculectomy

Substanzen

Angiogenesis Inhibitors

Autor:innen und Institutionen

  • Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
  • Department of Ophthalmology, Avantika Eye Care and Glaucoma Services, New Delhi, India.

Zitieren

APA

Verma, S., Midha, N., Udenia, H., & Dada, T. (2025). Updates in the treatment of neovascular glaucoma: From conventional approaches to novel therapies. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_841_25

Vancouver

Verma S, Midha N, Udenia H, Dada T. Updates in the treatment of neovascular glaucoma: From conventional approaches to novel therapies. Indian Journal of Ophthalmology. 2025. doi:10.4103/ijo.ijo_841_25

BibTeX
@article{Verma2025,
  author = {Verma, Saurabh and Midha, Neha and Udenia, Hemlata and Dada, Tanuj},
  title = {Updates in the treatment of neovascular glaucoma: From conventional approaches to novel therapies},
  journal = {Indian Journal of Ophthalmology},
  year = {2025},
  doi = {10.4103/ijo.ijo_841_25}
}
Kostenlos starten →